We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.38B
AUM Growth
-$153M
Cap. Flow
-$183M
Cap. Flow %
-13.3%
Top 10 Hldgs %
22.65%
Holding
854
New
26
Increased
138
Reduced
343
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 12.58%
2 Financials 10.21%
3 Consumer Discretionary 9.81%
4 Industrials 8.12%
5 Healthcare 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLV icon
276
Invesco S&P 500 Low Volatility ETF
SPLV
$7.1B
$315K 0.02%
5,730
+4,240
+285% +$228K
TRTN
277
DELISTED
Triton International Limited
TRTN
$314K 0.02%
9,596
-24,304
-72% -$769K
IWV icon
278
iShares Russell 3000 ETF
IWV
$20.2B
$309K 0.02%
1,795
EIRL icon
279
iShares MSCI Ireland ETF
EIRL
$79.7M
$300K 0.02%
7,214
-3,280
-31% -$139K
KLIC icon
280
Kulicke & Soffa
KLIC
$4.44B
$299K 0.02%
13,275
-38,640
-74% -$849K
HUN icon
281
Huntsman Corp
HUN
$1.69B
$297K 0.02%
14,533
-17,205
-54% -$361K
AYR
282
DELISTED
Aircastle Ltd
AYR
$292K 0.02%
13,730
-33,225
-71% -$670K
CVS icon
283
CVS Health
CVS
$121B
$290K 0.02%
5,335
-26,195
-83% -$1.41M
UFPI icon
284
UFP Industries
UFPI
$4.76B
$279K 0.02%
7,335
-15,055
-67% -$522K
ACOR
285
DELISTED
Acorda Therapeutics
ACOR
$278K 0.02%
302
-34
-10% -$41.8K
TMHC
286
DELISTED
Taylor Morrison
TMHC
$274K 0.02%
13,055
-26,720
-67% -$531K
VTIP icon
287
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
$270K 0.02%
5,465
DK icon
288
Delek US
DK
$4.34B
$268K 0.02%
6,605
-13,580
-67% -$497K
EPU icon
289
iShares MSCI Peru and Global Exposure ETF
EPU
$580M
$267K 0.02%
7,200
+1,600
+29% +$59.4K
WGO icon
290
Winnebago Industries
WGO
$871M
$267K 0.02%
6,920
-14,230
-67% -$501K
AAWW
291
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$267K 0.02%
5,993
-21,244
-78% -$932K
RMBS icon
292
Rambus
RMBS
$9.76B
$266K 0.02%
22,110
-45,180
-67% -$518K
TNL icon
293
Travel + Leisure Co
TNL
$4.51B
$266K 0.02%
6,050
-10,085
-63% -$430K
CCK icon
294
Crown Holdings
CCK
$13B
$265K 0.02%
4,345
-1,350
-24% -$78.7K
HLI icon
295
Houlihan Lokey
HLI
$9.07B
$263K 0.02%
5,906
-193
-3% -$9.02K
TKR icon
296
Timken Company
TKR
$8.74B
$263K 0.02%
5,130
-10,555
-67% -$504K
ALLY icon
297
Ally Financial
ALLY
$12.9B
$261K 0.02%
8,430
-17,300
-67% -$510K
SODA
298
DELISTED
SodaStream International Ltd
SODA
$261K 0.02%
1,807
-13,576
-88% -$1.96M
JBL icon
299
Jabil
JBL
$32.6B
$256K 0.02%
8,090
-16,615
-67% -$477K
RL icon
300
Ralph Lauren
RL
$21.6B
$256K 0.02%
2,250
-3,675
-62% -$440K

Similar funds

James Investment Research's Q2 2019 Portfolio in Review

As of Q2 2019, James Investment Research held 854 positions worth $1.38B, down 10% from $1.53B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

James Investment Research withdrew a net $183M in Q2 2019, closing 182 positions and reducing 343 holdings. Its most notable exit was Textron, an estimated $4.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, James Investment Research opened a new position in Kraft Heinz worth $5.02M.

  • James Investment Research's largest Q2 2019 buy was Kraft Heinz: 161,605 shares worth $5.02M.
  • James Investment Research added most to iShares 1-3 Year Treasury Bond ETF in Q2 2019, an estimated $14M increase.
  • James Investment Research's biggest Q2 2019 reduction was Micron Technology, cutting an estimated $12.5M.
  • James Investment Research fully exited Textron in Q2 2019, selling an estimated $4.36M.
  • James Investment Research's ten largest holdings make up 23% of its $1.38B portfolio in Q2 2019.
  • James Investment Research opened 26 new positions and closed 182 in Q2 2019.
  • James Investment Research's portfolio value fell 10% quarter-over-quarter to $1.38B.

Based on James Investment Research's 13F filing for Q2 2019, filed 24 Jul 2019.